Neumora Therapeutics, Inc. (NMRA) has 6 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $607K. Most recent filing: Aug. 21, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 21, 2026 filed Aug. 20, 2026 | Aurora Daljit Singh See Remarks | — | 0 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 20, 2026 | BERNS PAUL L See Remarks | $0 | 500,000 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 20, 2026 | Duncan Jason See Remarks | $0 | 375,000 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 20, 2026 | Milligan Michael Lee See Remarks | $0 | 175,000 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 20, 2026 | Pinto Joshua President & CEO | $0 | 500,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free